The role of gene polymorphisms in the susceptibility and therapeutic response of chronic immune thrombocytopenic purpura

Key Points

• The aim is to explore how genetic variations influence susceptibility to chronic immune thrombocytopenic purpura and treatment responses.
• Conducted genetic profiling of affected individuals
• Analyzed the relationship between gene polymorphisms and disease characteristics
• Investigated the impact on therapeutic response
• Identified specific gene polymorphisms associated with increased susceptibility
• Found correlations between genetic variations and treatment effectiveness
• Demonstrated potential for personalized treatment approaches to optimize outcomes

Abstract